The long-term impact of post-procedural asymmetry and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial.
26 August 2018 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Sapporo Higashi Tokushukai Hospital, Sapporo (Japan)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2018
26 August 2018
14:00 CET
